A novel phenolic glycolipid from Mycobacterium leprae possibly involved in immunogenicity and pathogenicity
- PMID: 7024248
- PMCID: PMC216107
- DOI: 10.1128/jb.147.3.728-735.1981
A novel phenolic glycolipid from Mycobacterium leprae possibly involved in immunogenicity and pathogenicity
Abstract
A phenolic glycolipid was obtained in high amounts (2% of dry weight) from Mycobacterium leprae isolated from infected armadillo liver. Infrared and nuclear magnetic resonance spectroscopy showed that it is closely related to "mycoside A" from Mycobacterium kansasii and is therefore a glycosylphenolic phthiocerol diester. The crucial difference between the two products is in the composition of the attached trisaccharide. Gas-liquid chromatography-mass spectroscopy showed that the product from M. kansasii is composed of 2,4-di-O-methylrhamnose, 2-O-methylrhamnose, and 2-O-methylfucose, whereas that from M. leprae contains 2,3-di-O-methylrhamnose, 3-O-methylrhamnose, and 3,6-di-O-methylglucose. The distinct composition of the oligosaccharide segment of the glycolipid from M. leprae may make it useful for the chemical and serological differentiation of this organism from other mycobacteria. Surprisingly large quantities (2.2 mg/g of dry liver) of the glycolipid were also found in infected liver residue freed of M. leprae, suggesting that it may be responsible for the electron-transparent "foam" surrounding the organism in infected lepromatous tissue.
Similar articles
-
Serological specificity of phenolic glycolipid I from Mycobacterium leprae and use in serodiagnosis of leprosy.Infect Immun. 1983 Sep;41(3):1077-83. doi: 10.1128/iai.41.3.1077-1083.1983. Infect Immun. 1983. PMID: 6193065 Free PMC article.
-
Structural elucidation of the major phenolic glycolipid from Mycobacterium kansasii. II. Presence of a novel dideoxyhexose.J Biol Chem. 1987 Mar 5;262(7):3180-4. J Biol Chem. 1987. PMID: 3818638
-
Isolation of the Mycobacterium leprae-specific glycolipid antigen, phenolic glycolipid-I, from formalin-fixed human lepromatous liver.J Clin Microbiol. 1985 Oct;22(4):680-2. doi: 10.1128/jcm.22.4.680-682.1985. J Clin Microbiol. 1985. PMID: 3908478 Free PMC article.
-
The role of Mycobacterium leprae phenolic glycolipid I (PGL-I) in serodiagnosis and in the pathogenesis of leprosy.Lepr Rev. 2011 Dec;82(4):344-57. Lepr Rev. 2011. PMID: 22439275 Review.
-
HLA and leprosy in the pre and postgenomic eras.Hum Immunol. 2006 Jun;67(6):439-45. doi: 10.1016/j.humimm.2006.03.009. Epub 2006 Apr 3. Hum Immunol. 2006. PMID: 16728267 Review.
Cited by
-
Early events in the host-parasite relationship and immune response in clinical leprosy: its possible importance for leprosy control.Clin Exp Immunol. 1983 Nov;54(2):289-97. Clin Exp Immunol. 1983. PMID: 6228348 Free PMC article. Review. No abstract available.
-
Treatment of leprosy in the United States.Bull N Y Acad Med. 1984 Sep;60(7):696-711. Bull N Y Acad Med. 1984. PMID: 6386081 Free PMC article. Review. No abstract available.
-
Mycobacterium leprae phenolglycolipid-1 expressed by engineered M. bovis BCG modulates early interaction with human phagocytes.PLoS Pathog. 2010 Oct 21;6(10):e1001159. doi: 10.1371/journal.ppat.1001159. PLoS Pathog. 2010. PMID: 20975946 Free PMC article.
-
Serological specificity of phenolic glycolipid I from Mycobacterium leprae and use in serodiagnosis of leprosy.Infect Immun. 1983 Sep;41(3):1077-83. doi: 10.1128/iai.41.3.1077-1083.1983. Infect Immun. 1983. PMID: 6193065 Free PMC article.
-
Functional Impairment of Skin Appendages Due to Peripheral Nerve Involvement by Mycobacterium leprae.Open Forum Infect Dis. 2020 Sep 12;7(10):ofaa419. doi: 10.1093/ofid/ofaa419. eCollection 2020 Oct. Open Forum Infect Dis. 2020. PMID: 33094119 Free PMC article.
References
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources